Bioavailability Systems, LLC Company Profile

10:44 EDT 25th September 2018 | BioPortfolio

BAS was founded in 1996 by James W. Harris, PhD and Robert A. Baugher as a limited liability company incorporated in Maryland. The company's goal was to pursue the identification and commercialization of active anti- First Pass Effect components in grapefruit. In 1997 Dr. Harris successfully isolated compounds from grapefruit demonstrated to be highly active through in-vitro tests as human CYP 3A inhibitors. The compounds are complex molecules containing an unusual spiro-ortho-ester (SOE) substructure. The structure of the SOE class of inhibitors was elucidated in May 1997 and the first of a series of patents was filed.


2210 S. Atlantic Avenue
Cocoa Beach
United States of America


Phone: (321) 784-2318
Fax: (321) 868-0038

News Articles [365 Associated News Articles listed on BioPortfolio]

Bioavailability increasing nanoparticle tech receives US patent

Nanoparticle delivery technology that transports compounds to the bloodstream and cells can increase bioavailability and reduce adverse effects of cannabinoids and bioactive compounds, says NanoSphere...

Lexaira Bioscience demonstrates high bioavailability in CBD platform

Lexaira Bioscience says its DehydraTECH platform has demonstrated significant improvements to the bioavailability of cannabinoids, and could be applied to other pharmaceuticals.

Significant Bioavailability Results in Human Clinical Trial using Lexaria’s DehydraTECH (TM) Powered TurboCBD (TM) Capsules

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, is pleased to report significant bioavailability results from its randomized, placeb...

Lexaria’s DehydraTECH Triples Bioavailability of CBD in Human Trial -- CFN Media

SEATTLE, Aug. 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publi...

The stage of seed development influences iron bioavailability in pea (Pisum sativum L.)

CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the O...

protein sequencers, variable wave length, capillary electrophoresis, liquid chromatography, gene array, medical equipment

Provider of, patient-monitoring, systems, point-of-care, diagnostics, systems, clinical-information, systems, ultrasound imaging, technologies, chemical analysis, systems

Auris Medical Announces Publication Confirming Dose-Dependent Effects of Betahistine and Relationship to Bioavailability in Cat Model of Acute Vertigo

Zug, Switzerland, July 3, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and m...

PubMed Articles [1268 Associated PubMed Articles listed on BioPortfolio]

A new perspective of using sequential extraction: To predict the deficiency of trace elements during anaerobic digestion.

Trace elements were commonly used as additives to facilitate anaerobic digestion. However, their addition is often blind because of the complexity of reaction conditions, which has impeded their wides...

Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability.

Self-emulsifying drug delivery systems (SEDDS) have been widely employed to improve the oral bioavailability of poorly soluble drugs. In the past few years, SEDDS were extensively investigated to over...

Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign.

Rosuvastatin calcium (ROSCa) is a poorly soluble drug with bioavailability not exceeding 20%. Decreasing the particle size may enhance its solubility, dissolution rate and bioavailability. Therefore, ...

Polyamidoamine (PAMAM) dendrimers as potential release modulators and oral bioavailability enhancers of Vardenafil hydrochloride.

Vardenafil hydrochloride (VAR) is an erectile dysfunction treating drug. VAR has a short elimination half-life (4-5 h) and suffers low oral bioavailability (15%). This work aimed to explore the dual...

Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2.

Self-emulsifying Drug Delivery Systems are being introduced and are increasing in popularity for improving the solubility of lipophilic drugs. They are isotropic mixtures of drug, oil, surfactant and/...

Clinical Trials [2029 Associated Clinical Trials listed on BioPortfolio]

Content, Bioavailability and Health Effects of Trace Elements and Bioactive Components in Organic Agricultural Systems

Trace elements, bioactive secondary metabolites and vitamins are among the most important quality parameters in plants. Yet, very little information is available on their content, bioavail...

Impact of Food Process and Mastication on Nutrient Bioavailability

This project aims at assessing - the impact of heat treatment on the bioavailability of meat carnosine and amino acids, - the interaction between masticatory efficiency and heat tr...

Dose Response Bioavailability of Coffee and Green Tea Antioxidants in Humans

Coffee and green tea are 2 widely consumed beverages. Both contain polyphenol antioxidant compounds (chlorogenic acids for coffee and catechins for tea). The bioavailability of catechins i...

Oxandrolone in Healthy Adults: A Relative Bioavailability Study

To assess the pharmacokinetics and relative bioavailability of a single dose of approximately 0.1 mg/kg of a medium chain triglyceride (MCT) oil oxandrolone solution vs. tablets in a small...

A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects

To evaluate the Bioavailability for GV-971 capsules of 150 mg, 300mg, and 450mg after administration of single oral doses of 900mg in healthy Male subjects.

Companies [1402 Associated Companies listed on BioPortfolio]

Phosphagenics Limited

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety ...


Synchron is a leading Contract Research Organisation in India providing broad range of clinical research services including bioavailability, bioequivalence and pharmacokinetic studies in compliance wi...

Bioavailability Systems, LLC

BAS was founded in 1996 by James W. Harris, PhD and Robert A. Baugher as a limited liability company incorporated in Maryland. The company's goal was to pursue the identification and commercialization...

HµREL Corporation

HµREL Corporation is a development-stage enterprise based in Beverly Hills, California. HµREL’s development is proceeding under the aegis of Athena Capital Partners, LLC, a Los Angeles enterprise ...

iVeena Delivery Systems, Inc.

iVeena Delivery Systems, Inc. (iVeena) is a privately held biopharmaceutical company that develops innovative ophthalmology products. iVeena utilizes a proprietary intracapsular d...

More Information about "Bioavailability Systems, LLC" on BioPortfolio

We have published hundreds of Bioavailability Systems, LLC news stories on BioPortfolio along with dozens of Bioavailability Systems, LLC Clinical Trials and PubMed Articles about Bioavailability Systems, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioavailability Systems, LLC Companies in our database. You can also find out about relevant Bioavailability Systems, LLC Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record